Navigation Links
Reportlinker Adds U.S. Market for Small Bone & Joint Orthopedic Devices 2009
Date:11/17/2009

/p>

Figure 7-5: Market Drivers and Limiters, Total Ankle Replacement Market, U.S., 2008

Figure 7-6: Leading Competitors, Combined Foot and Ankle Arthroplasty Market, 2008

Figure 7-7: Leading Competitors, Total Ankle Replacement Market, 2008

Figure 7-8: Leading Competitors, Combined Foot and Ankle Fusion Market, 2008

DIGIT REPLACEMENT MARKET

Figure 8-1: Hand Digit Arthroplasty Procedures, 2005 - 2015

Figure 8-2: Combined Market for Digit Implants, U.S., 2005 - 2015

Figure 8-3: Combined Digit Implant Procedures, U.S., 2008

Figure 8-4: Hand Digit Implant Market, U.S., 2005 - 2015

Figure 8-5: Foot Digit Implant Market, U.S., 2005 - 2015

Figure 8-6: Drivers and Limiters, Digit Replacement Market, 2008

Figure 8-7: Leading Competitors, Digit Replacement Market, 2008

NERVE CONDUIT MARKET

Figure 9-1: Nerve Conduit Market, U.S., 2005 - 2015

Figure 9-2: Drivers and Limiters, Nerve Conduit Market, 2008

Figure 9-3: Leading Competitors, Nerve Conduit Market

APPENDIX 1: ABBREVIATIONS

APPENDIX 2: SMALL CANNULATED SCREW MARKET

Figure 11-1: Combined Cannulated Screw Market, U.S., 2005 - 2015

Figure 11-2: Combined Cannulated Screw Market by Size, U.S., 2005 - 2015

Figure 11-3: Small Cannulated Screw Market, U.S., 2005 - 2015

Figure 11-4: Market Driver and Limiters, Cannulated Screws, U.S., 2008

Figure 11-5 Leading Competitors, Cannulated Screw Market, U.S., 2008

APPENDIX 3: SMALL AND MINI FRAGMENT PLATE AND SCREW MARKET

Figure 12-1: Plate and Screw Fragment Sizes

Figure 12-2: Total Plate and Screw Market, U.S., 2005 - 2015

Figure 12-3: Total Plate and Screw Units by Segment, U.S., 2005 - 2015

Figure 12-4: Small and Mini Fragment Plate and Screw Markets by Segmen
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Reportlinker Adds European Markets for Orthopedic Biomaterials 2009 (15 Countries)
2. Reportlinker Adds Brazil, Russian, Indian and Chinese Markets for Endoscopic Devices 2009 (4 Countries)
3. Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015
4. Reportlinker Adds United States Medical Equipment Market Analysis & Forecasts to 2015
5. Reportlinker Adds Metabolic Endocrinology Hypocalcemia
6. Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends
7. Reportlinker Adds The Future of the Wound Care Management Market to 2015
8. Reportlinker Adds The Prescribing Data Restriction Program: Critical Assessment and Best Practices
9. Reportlinker Adds The Global Drug Delivery Market: Research Trends and Market Outlook
10. Reportlinker Adds Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006
11. Reportlinker Adds Pain Therapeutics 2005: Market Dynamics and Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... Feb. 27, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... both its pro forma net operating loss (NOL) guidance ... strong financial position.  Isis, significantly improved financial results were ... million in payments the Company received from its partners.  ... was a nearly 60% improvement over its 2013 NOL ...
(Date:2/27/2015)... Mass. , Feb. 27, 2015   Synageva ... ), a biopharmaceutical company developing therapeutic products for ... Disorders™ (NORD™), the European Organisation for Rare Diseases™ ... the world in observing Rare Disease Day. ... year, patient organizations, industry, and other participants conduct ...
(Date:2/27/2015)... 27, 2015 ... für kongestive Herzinsuffizienz (CHF) in seiner ersten ...     Die israelische ... Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz (CHF) ... ein Finanzierungsvorhaben über 5 Mio. USD abgeschlossen ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2
... ANNAPOLIS, Md., March 31 PharmAthene, Inc. (NYSE Amex: ... against biological and chemical threats, announced today that new ... the Keystone Symposia on Molecular and Cellular Biology Conference ... Alberta. The data were presented by Dr. Alan ...
... 31 QuatRx Pharmaceuticals, a privately-held biopharmaceutical company, today ... second pivotal Phase 3 clinical trial of Ophena(TM) ... pivotal Phase 3 study of Ophena(TM) , the ... studies for Ophena(TM) , the most advanced estrogen-free ...
Cached Medicine Technology:Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 2Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 3Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 4Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 5Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology 6QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 2QuatRx Completes Enrollment of Ophena(TM)(Ospemifene Tablets) Final Pivotal Phase 3 Study in Women with Postmenopausal Vaginal Atrophy 3
(Date:2/28/2015)... (PRWEB) March 01, 2015 Heart diseases ... that 10 percent of urban adult population and 5 ... of heart diseases and 20-30 percent of them require ... heart ailments and coronary vascular diseases (CVD). , A ... a new market research report titled “Indian Coronary Stent ...
(Date:2/28/2015)... 2015 The Heart Fit Clinic started ... of the machine. The Heart Fit Clinic is also ... a franchise model. The goal is to scale the ... disease. To buy External Counterpulsation machines can ... individuals through this process and achieve the desired results. ...
(Date:2/28/2015)... Vancouver personal injury lawyers at Jiwa Law Corporation recently ... limits. They stated that in many cases, missing an important ... it. Many a time, delays in making an injury claim ... law. As a result, experts at Jiwa Law Corporation suggest ... personal injury lawyer in order to know more about their ...
(Date:2/28/2015)... The Mesothelioma Applied Research Foundation ... International Symposium on Malignant Mesothelioma on Monday, March 2. ... Regency Bethesda in Bethesda, Maryland. The following award recipients ... to the mission to cure mesothelioma. , The Klaus ... to Miriam Ratner. Miriam runs the Meso Foundation’s monthly ...
(Date:2/28/2015)... Orlando, FL (PRWEB) February 28, 2015 ... community organization has sponsored visitor health insurance programs for ... 25 years. Most Indian elderly parents traveling to the ... conditions such as diabetes and blood pressure. These diseases ... do not even list them as medical conditions. There ...
Breaking Medicine News(10 mins):Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3
... urinate, affects the quality of life of many women. ... can tolerate oral medications and may benefit from other therapies. ... is conducting a study to compare the effect of two ... trying other treatments. Patients are currently being enrolled in ...
... February 29, 2012 A new method for creating ... Institute of New York University (NYU-Poly), promises to greatly ... heart disorders and Alzheimer,s disease, as well as aid ... , In addition, applied differently, this same development could ...
... new way of measuring the potential success rate of an ... in vitro fertilisation (IVF). According to the findings published ... fluid within a woman,s ovaries that surrounds the egg or ... embryo is more likely to lead to pregnancy. "We ...
... TUESDAY, Feb. 28 (HealthDay News) -- Taking the hallucinogen ecstasy ... lead to poorer motor control in infants, a new study ... history before and during pregnancy. The women were taking part ... which looks at recreational drug use among pregnant women. Most ...
... elderly cancer patients are evolving as more of the population ... To address these issues and others, national thought leaders ... the Kimmel Cancer Center at Jefferson (KCC) in ... an overview of the latest advances in the understanding and ...
... all deaths in the United States are linked to behavioral ... Despite these causal links, of the $2 trillion spent annually ... that is devoted to addressing behavioral and social risk factors. ... behavioral and social sciences with a new $500,000 grant from ...
Cached Medicine News:Health News:Women & Infants studying therapies to relieve urinary urge incontinence 2Health News:Nanofiber breakthrough holds promise for medicine and microprocessors 2Health News:New test can better predict successful IVF embryos, scientists say 2Health News:Ecstasy Use During Pregnancy May Harm Fetus: Study 2Health News:A new battlefront: Symposium at Jefferson's Kimmel Cancer Center to tackle geriatric oncology 2Health News:A new battlefront: Symposium at Jefferson's Kimmel Cancer Center to tackle geriatric oncology 3Health News:Training grant targets behavioral and social factors linked to health 2Health News:Training grant targets behavioral and social factors linked to health 3
POLYSORB™ sutures are composed of LACTOMER™ glycolide/lactide copolymer which is a synthetic polyester composed of glycolide and lactide (derived from glycolic and lactic acids)....
Surgitie&trade Single Use Ligating Loops with Delivery System...
ENDO SLIDE™ single use knot pusher with 12 units per box....
ENDO STITCH™ Single Use Loading Units....
Medicine Products: